Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Cullinan Oncology (NASDAQ:CGEM)

CAMBRIDGE, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (NASDAQ:CGEM) ("Cullinan Oncology") a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announced

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Chad , San Francisco , California , United States , Rose Weldon , Nadim Ahmed , Cullinan Oncology Inc , Twitter , Linkedin , Cullinan Oncology , Chief Executive Officer , Healthcare Conference ,